Infinity Pharmaceuticals

Infinity Pharmaceuticals Net Debt/Equity

The Net Debt to Equity Ratio of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 1.96. In the previous year, Net Debt to Equity Ratio was -3.68 — a change of -153.40% (higher).

Net Debt/Equity

1.96

YoY

-153.40%

Last updated:

Net Debt to Equity Ratio of Infinity Pharmaceuticals is 2022 1.96 . Net Debt to Equity Ratio of Infinity Pharmaceuticals was 2021 -3.68 . It decreases by -153.40% higher compared to the previous year.

The Infinity Pharmaceuticals Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2015
-2.28 USD
Jan 1, 2016
-0.88 USD
Jan 1, 2017
-1.08 USD
Jan 1, 2018
-1.12 USD
Jan 1, 2019
-5.20 USD
Jan 1, 2020
0.46 USD
Jan 1, 2021
-3.68 USD
Jan 1, 2022
1.96 USD
The Infinity Pharmaceuticals Net Debt/Equity history
YEARNet Debt/EquityYoY
1.96-153.40%
-3.68-895.39%
0.46-108.90%
-5.20+365.43%
-1.12+3.18%
-1.08+23.10%
-0.88-61.52%
-2.28+43.82%
-1.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Net Debt to Equity Ratio of Infinity Pharmaceuticals is 1.96 in 2022.

Net Debt to Equity Ratio of Infinity Pharmaceuticals changed from -3.68 to 1.96, representing a -153.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals